• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Fansidar用于治疗弓形虫病]

[Fansidar in the treatment of toxoplasmosis].

作者信息

Michalová K, Ríhová E, Havlíková M

机构信息

I. ocní klinika 1. LF UK, Praha.

出版信息

Cesk Slov Oftalmol. 1996 Jul;52(3):173-8.

PMID:8768475
Abstract

Toxoplasmosis chorioretinitis is the most frequent posterior uveitis. Different treatment modes are used for its therapy. Classical is the combination of 50 mg of pyrimethamine with 4 g of sulphadiazine and corticosteroids. In this study the results of treatment with lower doses of pyrimethamine together with long-acting sulphonamide are reported. Twelve patients were treated with Fansidar, combination of 25 mg of pyrimethamine and 500 mg sulphadoxine. The treatment consisted of a loading dose of two tablets of Fansidar, followed by one tablet a day. Prednisone 0.5 mg/kg/day was added and gradually tapered off. Patients were treated for 28 days on average (range 21-50 days). In 83% of patients the scar was considerably smaller than original lesion (on average the scar represented 25% of original lesion). Three months after the treatment the visual acuity was 6/9 or better in 83% of patients. No side-effects of the treatment were observed. Lower doses of pyrimethamine with suphadoxine in an easy once a day treatment regime could be an alternative and cost-effective therapy for ocular toxoplasmosis.

摘要

弓形虫性脉络膜视网膜炎是最常见的后葡萄膜炎。其治疗采用不同的治疗方式。经典的治疗方法是将50毫克乙胺嘧啶与4克磺胺嘧啶及皮质类固醇联合使用。本研究报告了低剂量乙胺嘧啶与长效磺胺联合治疗的结果。12例患者接受了 Fansidar(25毫克乙胺嘧啶与500毫克周效磺胺的组合)治疗。治疗开始时服用两片 Fansidar作为负荷剂量,之后每天服用一片。加用泼尼松0.5毫克/千克/天,并逐渐减量。患者平均治疗28天(范围为21 - 50天)。83%的患者瘢痕明显小于原病变(平均瘢痕面积占原病变的25%)。治疗三个月后,83%的患者视力达到6/9或更好。未观察到治疗的副作用。低剂量乙胺嘧啶与周效磺胺,采用简便的每日一次治疗方案,可能是眼部弓形虫病的一种替代且经济有效的治疗方法。

相似文献

1
[Fansidar in the treatment of toxoplasmosis].[Fansidar用于治疗弓形虫病]
Cesk Slov Oftalmol. 1996 Jul;52(3):173-8.
2
Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.甲氧苄啶/磺胺甲恶唑与乙胺嘧啶和磺胺嘧啶治疗眼部弓形虫病的前瞻性随机试验。
Ophthalmology. 2005 Nov;112(11):1876-82. doi: 10.1016/j.ophtha.2005.05.025. Epub 2005 Sep 19.
3
[Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar].[复发性先天性眼弓形虫病的治疗。我们使用 Fansidar 的初步经验]
Bull Soc Ophtalmol Fr. 1989 Apr;89(4):567-8, 571-2.
4
Central nervous system toxoplasmosis in adult Ethiopians.成年埃塞俄比亚人的中枢神经系统弓形虫病
Ethiop Med J. 2006 Apr;44(2):113-20.
5
Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.
Bone Marrow Transplant. 1994 Aug;14(2):241-5.
6
[Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].[广泛型弓形体性视网膜脉络膜炎。诊断与治疗管理]
J Fr Ophtalmol. 2003 Nov;26(9):921-7.
7
Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.阿托伐醌用于治疗免疫功能正常患者的弓形虫性视网膜脉络膜炎。
Ophthalmology. 1999 Jan;106(1):148-53. doi: 10.1016/S0161-6420(99)90021-0.
8
[Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].[弓形虫病的治疗。弓形虫性脉络膜视网膜炎的治疗]
J Fr Ophtalmol. 1990;13(11-12):551-3.
9
Efficacy of Sulphadoxine and Pyrimethamine, Doxycycline and their combination in the treatment of chloroquine resistant Falciparum Malaria.周效磺胺与乙胺嘧啶、强力霉素及其联合用药治疗氯喹抗性恶性疟的疗效
Saudi Med J. 2001 Aug;22(8):690-3.
10
[Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].[乙胺嘧啶和磺胺多辛作为卡氏肺孢子虫和弓形虫性脑炎的预防性治疗]
Enferm Infecc Microbiol Clin. 1999 Aug-Sep;17(7):347-9.

引用本文的文献

1
Fansidar drug induces cytotoxicity in some vital tissues in a rat model: combination defensive effect of selenium and zinc capsules.Fansidar药物在大鼠模型的一些重要组织中诱导细胞毒性:硒和锌胶囊的联合防御作用。
Ther Adv Drug Saf. 2021 Jul 15;12:20420986211027101. doi: 10.1177/20420986211027101. eCollection 2021.